Tuesday’s Top Biopharma Movers
A few biopharma stocks made massive runs on Tuesday morning as the result of clinical trial results and earnings. Although not all of these moves were positive the overall sentiment was positive.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 173
Why Catalyst Bio Nearly Tripled
Catalyst Biosciences saw its shares practically triple in Tuesday’s session after the company announced a critical regulatory approval.
Short Interest Pulls Back in Major Biotechs
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Analyst Calls for Exponential Upside for Idera Pharmaceuticals
Idera Pharmaceuticals is focused on cancer and rare diseases, and it could be a what traders refer to as a three-bagger or four-bagger, if two analysts who made key calls in recent days end…
How Health Care Stocks Responded to the Shelved Health Care Bill
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
2 Health Care Stocks Crushed on Thursday
Should Trump’s new health care bill pass, investors might gain confidence that the president can actually push his agenda, while a failure to pass could send the markets lower.
How a Key European Decision Is Making All the Difference at HTG
HTG Molecular Diagnostics saw its shares make a massive move to the upside after the company announced that it has obtained CE Marking in the European Union for its HTG EdgeSeq ALKPlus Assay EU.
Regenxbio Sinks After Announcing Secondary Offering
Regenxbio plans to offer more than 3 million shares of common stock in a secondary offering valued up to more than $87 million.
Why Pulmatrix Investors Are Breathing a Sigh of Relief
Pulmatrix saw its shares take a massive jump on Tuesday after the company announced that it received a crucial patent approval in Europe.
5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts
A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove to be huge.
Monday’s Top Biopharma Movers
Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.
Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now
These are four top stocks to buy in a sector that has much more value than many on Wall Street. All are rated Buy at Jefferies and have outstanding upside potential.
Wednesday’s Biggest Biopharma Movers
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about 1% on…
Is Valeant Finished Now That Ackman Is Out of the Picture?
Valeant Pharmaceuticals shares hit a multiyear low on Tuesday after it was announced that Bill Ackman would be selling off his stake in the company and stepping down from the board.